TANGO THERAPEUTICS INC. - COMMON STOCK

Tango Therapeutics Announces Clearance of TNG908 IND by FDA and Recent Pipeline Progress Updates

24 1月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Tango Therapeutics to Participate in the Jefferies London Healthcare Conference

11 11月 2021 07:00:01 条件 Nasdaq GlobeNewswire

Tango Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Highlights

09 11月 2021 07:00:02 条件 Nasdaq GlobeNewswire

Tango Therapeutics Announces Appointment of Dr. Marc Rudoltz as Chief Medical Officer and Doug Barry as General Counsel

01 11月 2021 07:00:00 条件 Nasdaq GlobeNewswire

Tango Therapeutics Debuts as Publicly Traded Precision Oncology Company Focused on the Next Generation of Targeted Cancer Therapies

10 8月 2021 09:00:01 条件 Nasdaq GlobeNewswire